Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study

• Sanne C. van Kampen ,

  * E-mail: sanne.vankampen@kncvtbc.org

  Affiliation Access to Laboratory Services Team, KNCV Tuberculosis Foundation, The Hague, the Netherlands

  ⨯
• Nugroho H. Susanto,

  Affiliations Medical Faculty, Universitas Padjadjaran, Bandung, Indonesia, Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia

  ⨯
• Sumanto Simon,

  Affiliations Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia, Medical Faculty, Universitas Atmadjaja, Jakarta, Indonesia

  ⨯
• Shinta D. Astiti,

  Affiliation Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia

  ⨯
• Roni Chandra,

  Affiliation Laboratory Team TB CARE I, KNCV Tuberculosis Foundation, Jakarta, Indonesia

  ⨯
• Erlina Burhan,

  Affiliation Department of Lung and Respiratory Health, Persahabatan Hospital, Jakarta, Indonesia

  ⨯
• Muhammad N. Farid,

  Affiliations Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia, Sub-Directorate Statistics and Design, Central Bureau of Statistics, Jakarta, Indonesia

  ⨯
• Kendra Chittenden,

  Affiliation Health Division, United States Agency for International Development, Jakarta, Indonesia

  ⨯
• Dyah E. Mustikawati,

  Affiliation National Tuberculosis Control Program, Ministry of Health, Jakarta, Indonesia

  ⨯
• Bachti Alisjahbana

  Affiliations Medical Faculty, Universitas Padjadjaran, Bandung, Indonesia, Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia

  ⨯